We showed that engrafted hNSCs significantly reduced the stroke-induced elevated MMP-9 level 48 hours post-MCAO/R, suggesting that hNSCs can ameliorate BBB disruption by inhibiting the elevated enzyme’s associated harmful events. This evidence concerns the gene MMP9 and Stroke.